dc.contributor
Institut Català de la Salut
dc.contributor
[Macarulla T] Servei d’Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. [Adeva J] Medical Oncology Department, Hospital Universitario, 12 de Octubre, Madrid, Spain. [Cano Osuna MT] Medical Oncology Department, Hospital Universitario Reina Sofía, Córdoba, Spain. [Ruiz Casado A] Medical Oncology Department, Hospital Universitario Puerta de Hierro Majadahonda, Madrid, Spain. [Jiménez Gordo AM] Medical Oncology Department, Hospital Universitario Infanta Sofía, Madrid, Spain. [Lamarca A] Medical Oncology Department, Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain
dc.contributor
Vall d'Hebron Barcelona Hospital Campus
dc.contributor.author
Cano Osuna, Maria Teresa
dc.contributor.author
Ruiz-Casado, Ana
dc.contributor.author
Jiménez Gordo, Ana Maria
dc.contributor.author
Macarulla, Teresa
dc.contributor.author
Adeva, Jorge
dc.contributor.author
Lamarca, Angela
dc.date.accessioned
2025-10-24T10:43:16Z
dc.date.available
2025-10-24T10:43:16Z
dc.date.issued
2025-08-12T11:45:12Z
dc.date.issued
2025-08-12T11:45:12Z
dc.identifier
Macarulla T, Adeva J, Cano Osuna MT, Ruiz Casado A, Jiménez Gordo AM, Lamarca A, et al. SEOM-GEMCAD-TTD clinical guidelines for biliary tract cancer (2025). Clin Transl Oncol. 2025 Aug;27:3293-306.
dc.identifier
http://hdl.handle.net/11351/13530
dc.identifier
10.1007/s12094-025-03916-y
dc.identifier
001499196300001
dc.identifier.uri
https://hdl.handle.net/11351/13530
dc.description.abstract
Biliary tract cancer; Diagnosis; Precision medicine
dc.description.abstract
Cáncer del tracto biliar; Diagnóstico; Medicina de precisión
dc.description.abstract
Càncer del tracte biliar; Diagnòstic; Medicina de precisió
dc.description.abstract
Biliary tract cancers (BTC) are aggressive and fatal. Early recognition of symptoms and proper diagnostic work up allow for precise histopathological and molecular classification as well as accurate evaluation of the extent of disease. Surgery is the only potentially curative therapy in localized stages; however, disease recurrence is common and adjuvant chemotherapy appears to improve survival. Upfront systemic chemotherapy with immunotherapy is the treatment of choice in unresectable locally-advanced and metastatic disease. Inroads made in understanding its molecular biology has enabled new therapeutic targets to be identified with current indications and encouraging results that could further improve BTC patients' survival and quality of life.
dc.format
application/pdf
dc.relation
Clinical and Translational Oncology;27
dc.relation
https://doi.org/10.1007/s12094-025-03916-y
dc.rights
Attribution-NonCommercial-NoDerivatives 4.0 International
dc.rights
http://creativecommons.org/licenses/by-nc-nd/4.0/
dc.rights
info:eu-repo/semantics/openAccess
dc.subject
Tracte biliar - Càncer - Tractament
dc.subject
Tracte biliar - Càncer - Diagnòstic
dc.subject
DISEASES::Neoplasms::Neoplasms by Site::Digestive System Neoplasms::Biliary Tract Neoplasms
dc.subject
Other subheadings::Other subheadings::/diagnosis
dc.subject
HEALTH CARE::Health Services Administration::Patient Care Management::Disease Management
dc.subject
ENFERMEDADES::neoplasias::neoplasias por localización::neoplasias del sistema digestivo::neoplasias del tracto biliar
dc.subject
Otros calificadores::Otros calificadores::/diagnóstico
dc.subject
ATENCIÓN DE SALUD::administración de los servicios de salud::gestión de la atención al paciente::tratamiento de las enfermedades
dc.title
SEOM-GEMCAD-TTD clinical guidelines for biliary tract cancer (2025)
dc.type
info:eu-repo/semantics/article
dc.type
info:eu-repo/semantics/publishedVersion
